IP Verse

Gedeon Richter Pharma Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Gedeon Richter Pharma Gmbh

Patent Number:
EP4019041
Title:
Toxicity Management For Anti-Tumor Activity Of Cars
Applicant:
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Opposition Date:
Sep 28, 2023
Patent Number:
EP2578231
Title:
Antitumor T Cell Response Enhancer
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Jul 25, 2023
Patent Number:
EP3433276
Title:
Early Intervention Methods To Prevent Or Ameliorate Toxicity
Applicant:
SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE)
Opposition Date:
Sep 20, 2022
Patent Number:
EP2872171
Title:
Toxicity Management For Anti-Tumor Activity Of Cars
Applicant:
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Opposition Date:
Oct 6, 2021
Patent Number:
EP3338794
Title:
Toxicity Management For Anti-Tumor Activity Of Cars
Applicant:
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Opposition Date:
Nov 25, 2020

Competitors of Gedeon Richter Pharma Gmbh

THE CHILDREN'S HOSPITAL OF PHILADELPHIA

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

CHUGAI SEIYAKU KABUSHIKI KAISHA

Want to track Gedeon Richter Pharma Gmbh?

Feel free to send us a message here and we will get back to you